Halozyme Therapeutics Inc
HALO
NASDAQ
Biotechnology
$98.66
USD
-2.01 (-2.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $11.43B
Volume 1.7M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma Inc | $15.84B | - | +355.2% | - | |
NBIX | Neurocrine Biosciences Inc | $15.51B | 21.99 | +34.4% | - | |
BMRN | BioMarin Pharmaceutical Inc | $13.35B | 182.98 | +11.2% | - | |
EXEL | Exelixis Inc | $12.52B | 14.54 | +9.2% | - | |
ARWR | Arrowhead Pharmaceuticals Inc | $12.21B | - | +16.9% | - | |
MDGL | Madrigal Pharmaceuticals Inc | $11.91B | - | +149.0% | - | |
SMMT | Summit Therapeutics Inc | $11.86B | - | - | - | |
HALO | Halozyme Therapeutics Inc | $11.55B | 27.93 | +41.1% | - | |
PRAX | Praxis Precision Medicines Inc | $10.25B | - | - | - | |
APGE | Apogee Therapeutics Inc | $10.18B | - | - | - |
Top Peer by Growth
Madrigal Pharmaceuticals Inc
+149.0% YoY Revenue
Lowest P/E Ratio
Exelixis Inc
14.54x P/E
Best 1-Year Return
Praxis Precision Medicines Inc
+697.2% Return